A specialized company in yeast-cultivated mushroom mycelium (truffle, Phellinus, and Reishi)
In the New Year of 2026,
I was honored to be appointed as Co-Chief Executive Officer
of REXPHARM alongside CEO Seo Kyu Sur,
answering the company’s call to serve.
I sincerely hope that my knowledge and experience in
traditional Korean herbal medicine will contribute meaningfully to the development of REXPHARM’s products and to the continued expansion of the company’s sales and growth.
To all REXPHARM employees,
to our valued shareholders and members,
and to everyone who supports and loves REXPHARM,
I wish you greater happiness and prosperity in the year ahead.
Director, Pyeongtaek Giunchan Korean Medicine Hospital
Master of Korean Medicine
Rexpharm.Corp
CEO/Jai Kong Joo
In the fast-evolving healthcare industry, REXPHARM has grown by building its core strengths on technology, execution capability, and trust.
We go beyond simple manufacturing — we continuously challenge ourselves to understand what the market and our customers truly need, and we strive to prove our value through results.
With validated strategies and bold execution, REXPHARM manages risks effectively and sets a higher standard for itself.
We believe that this ongoing commitment will strengthen our organization and enable us to see further into the future.
Going forward, REXPHARM will broaden its perspective across the entire healthcare industry, pursuing sustainable growth and responsible innovation.
REXPHARM will take action.
Thank you.
Rexpharm.Corp
CEO/Kyu Sur